$1 million award for healthcare innovations to reduce child deaths
Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) and Save the Children have together announced a new $1 million award to support innovation in healthcare across the developing world that can reduce child deaths.
To be eligible for the Healthcare Innovation Award, organisations can come from the non-profit, private or public sector, but both the organisation and the innovation must come from the developing world. The innovation being nominated must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicated.
The winning organisation will receive $250,000 to further progress its work. An additional $750,000 will be made available for runners-up awards.
Advertisement
The award judges will be co-chaired by Sir Andrew Witty, CEO of GSK, and Justin Forsyth, CEO of Save the Children, and will consist of experts from the fields of public health, science and academia.
The Healthcare Innovation Award is the first joint initiative announced following the launch of an major new partnership between GSK and Save the Children which aims to save the lives of a million of the world’s poorest children.
Sir Andrew Witty, CEO of GSK, said: "Often the best solutions to a particular challenge come from those living and working closest to it. We recognise this and we are committed to supporting those working in the world’s poorest countries to improve health outcomes. This award will identify the most effective ideas being put into practice in developing countries and, by providing much needed funding, will enable these innovations to be scaled-up to reduce childhood deaths and will inspire others in the process."
Applications or nominations for the Healthcare Innovation Award close on 25 August 2013 at 11:59pm (GMT). Winners will be announced in November 2013.